While testicular cancer is rare compared with other types of cancer, it is the most common cancer in American males ages 15 to 35. Testicular cancer is highly treatable, even when cancer has spread beyond the testicle. Several treatments or a combination of treatments are available, and long-term survival rates are greater than 90%.
As a part of men's health and the Movember Foundation's focus on testicular cancer, Dr. Matthew Ziegelmann, a Mayo Clinic urologist, joins the Mayo Clinic Q&A podcast to discuss diagnosis and treatment of testicular cancer.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.